digraph "Patients suffering from cancers driven by any of these Ras mutations are excluded from treatment with cetuximab ( colorectal cancer ) or erlotinib ( lung adenocarcinoma ) because these treatments are ineffective for cancers with these Ras mutations and may even increase rates of progression ." {
label="Patients suffering from cancers driven by any of these Ras mutations are
excluded from treatment with cetuximab ( colorectal cancer ) or erlotinib ( lung
adenocarcinoma ) because these treatments are ineffective for cancers with these
Ras mutations and may even increase rates of progression .";
excluded13 [style=filled, fillcolor=white, label=excluded];
Patients1 [style=filled, fillcolor=white, label=Patients];
excluded13 -> Patients1  [label=nsubjpass];
suffering2 [style=filled, fillcolor=white, label=suffering];
Patients1 -> suffering2  [label=vmod];
cancers4 [style=filled, fillcolor=white, label=cancers];
suffering2 -> cancers4  [label=prep_from];
driven5 [style=filled, fillcolor=white, label=driven];
cancers4 -> driven5  [label=vmod];
any7 [style=filled, fillcolor=white, label=any];
driven5 -> any7  [label=agent];
mutations11 [style=filled, fillcolor=white, label=mutations];
these9 [style=filled, fillcolor=white, label=these];
mutations11 -> these9  [label=det];
Ras10 [style=filled, fillcolor=white, label=Ras];
mutations11 -> Ras10  [label=nn];
any7 -> mutations11  [label=prep_of];
are12 [style=filled, fillcolor=white, label=are];
excluded13 -> are12  [label=auxpass];
excluded13 -> excluded13  [label=root];
treatment15 [style=filled, fillcolor=white, label=treatment];
excluded13 -> treatment15  [label=prep_from];
cetuximab17 [style=filled, fillcolor=white, label=cetuximab];
excluded13 -> cetuximab17  [label=prep_with];
cancer20 [style=filled, fillcolor=white, label=cancer];
colorectal19 [style=filled, fillcolor=white, label=colorectal];
cancer20 -> colorectal19  [label=amod];
cetuximab17 -> cancer20  [label=appos];
erlotinib23 [style=filled, fillcolor=white, label=erlotinib];
cetuximab17 -> erlotinib23  [label=conj_or];
adenocarcinoma26 [style=filled, fillcolor=white, label=adenocarcinoma];
lung25 [style=filled, fillcolor=white, label=lung];
adenocarcinoma26 -> lung25  [label=nn];
cetuximab17 -> adenocarcinoma26  [label=appos];
ineffective32 [style=filled, fillcolor=white, label=ineffective];
because28 [style=filled, fillcolor=white, label=because];
ineffective32 -> because28  [label=mark];
treatments30 [style=filled, fillcolor=white, label=treatments];
these29 [style=filled, fillcolor=white, label=these];
treatments30 -> these29  [label=det];
ineffective32 -> treatments30  [label=nsubj];
are31 [style=filled, fillcolor=white, label=are];
ineffective32 -> are31  [label=cop];
excluded13 -> ineffective32  [label=advcl];
cancers34 [style=filled, fillcolor=white, label=cancers];
ineffective32 -> cancers34  [label=prep_for];
mutations38 [style=filled, fillcolor=white, label=mutations];
these36 [style=filled, fillcolor=white, label=these];
mutations38 -> these36  [label=det];
Ras37 [style=filled, fillcolor=white, label=Ras];
mutations38 -> Ras37  [label=nn];
cancers34 -> mutations38  [label=prep_with];
increase42 [style=filled, fillcolor=white, label=increase];
may40 [style=filled, fillcolor=white, label=may];
increase42 -> may40  [label=aux];
even41 [style=filled, fillcolor=white, label=even];
increase42 -> even41  [label=advmod];
ineffective32 -> increase42  [label=conj_and];
rates43 [style=filled, fillcolor=white, label=rates];
increase42 -> rates43  [label=dobj];
progression45 [style=filled, fillcolor=white, label=progression];
rates43 -> progression45  [label=prep_of];
}
